Estrogen News and Research

Latest Estrogen News and Research

Soy protein not effective in improving memory in post menopausal women

No beneficial effects were found on cognitive function, bone mineral density or plasma lipids when postmenopausal women age 60 years or older took soy protein supplements with isoflavones for one year

7 Jul 2004

Convincing evidence that at dietary levels, the estrogens found in soy do not stimulate cell growth and other markers for cancer risk

New research in monkeys suggests that a diet high in the natural plant estrogens found in soy does not increase the risk of breast or uterine cancer in postmenopausal women.

7 Jul 2004

Questions about this once widely-accepted treatment for postmenopausal ills

In the past two years, the Women’s Health Initiative (WHI) trials of Premarin-based hormone therapy came to early ends because the risks outweighed the benefits.

2 Jul 2004

Hormone replacement therapy in women increases risk of dementia

These "surprising and significant findings" are reported in two studies from the Women's Health Initiative Memory Study, in which UC Medical Center participates, in today's issue of the Journal of the American Medical Association (JAMA).

28 Jun 2004

Findings from WHI memory study may not directly apply to newly menopausal women

The WHIMS article reported that estrogen therapy does not decrease, but may increase, the risk of probable dementia in women age 65 and older using hormones compared to women taking placebo.

23 Jun 2004

Estrogen therapy may increase the risk for dementia

A new study in the Journal of the American Medical Association (JAMA) suggests that estrogen therapy does not decrease, but may increase, the risk for dementia in older, postmenopausal women.

22 Jun 2004

Line-dancing stamps out osteoporosis

Line-dance classes are helping a Griffith University student from the School of Physiotherapy and Exercise Science in her quest to stamp out osteoporosis.

21 Jun 2004

Intrinsa patch increases sexual desire in menopausal women

Data released from a second, large-scale safety and efficacy study showed treatment with Intrinsa, an investigational female testosterone patch, significantly increased satisfying sexual activity and sexual desire in menopausal women

17 Jun 2004

Cancer drug gefitinib (Iressa) may be able to restore tamoxifen's anticancer activity

A new study has found a possible mechanism for tamoxifen resistance in breast cancer and provides evidence that another cancer drug--gefitinib (Iressa)--may be able to restore tamoxifen's anticancer activity.

15 Jun 2004

African-American women less likely to survive breast cancer than white women

A new study led by investigators at Fred Hutchinson Cancer Research Center may help explain why African-American women with breast cancer are more likely to be diagnosed with advanced disease and are less likely to survive the disease than white women.

15 Jun 2004

Biologist has identified gene patterns that characterize a biologically distinct subtype of estrogen receptor negative breast tumor

University of North Carolina molecular biologist Charles Perou has identified the pattern of genes that characterize a biologically distinct subtype of estrogen receptor negative breast tumor.

14 Jun 2004

Cholesterol isn’t all bad

Cholesterol gets lots of bad press, and for good reason. An estimated 24 million women and 18 million men have total cholesterol levels of 240 milligrams per deciliter (mg/dL) or higher increasing their risk of heart attack and stroke.

11 Jun 2004

Better understanding of Tamoxifen and how breast cancer patients develop resistance

A new study by researchers at Georgetown’s Lombardi Comprehensive Cancer Center may have implications for the thousands of breast cancer patients who develop resistance to antiestrogen drugs such as Tamoxifen®. The work is published in the June 1 issue of Cancer Research.

11 Jun 2004

New treatment significantly improves long-term outlook for breast cancer survivors

An updated analysis from an international clinical trial of the drug letrozole was presented on June 8, 2004 at the American Society of Clinical Oncology annual meeting in New Orleans.

11 Jun 2004

Epilepsy drugs can increase the rate of bone loss in older women

Epilepsy drugs can increase the rate of bone loss in older women, according to a study published in the June 8 issue of Neurology, the scientific journal of the American Academy of Neurology.

9 Jun 2004

Genetic link between hormones and migraine

Director of the Genomics Research Centre Professor Lyn Griffiths and her team of researchers at Griffith University have identified a genetic link between hormones and migraine.

9 Jun 2004

Gene mutation found in some women may decrease effectiveness of tamoxifen breast cancer drug

Researchers from the Johns Hopkins Kimmel Cancer Center, Indiana University and the University of Michigan have found that some women have a gene mutation that may decrease the effectiveness of tamoxifen, a commonly used breast cancer drug.

7 Jun 2004

Serum estrogen receptor modulator's (SERM's) may help reduce postmenopausal breast cancer risk

Newest research findings were presented on the possible benefits they may provide for postmenopausal breast cancer risk reduction. SERMs are a class of drugs that can block the cell's ability to use estrogen to stimulate the development of breast cancer.

7 Jun 2004

Discovery of a key marker in breast cancer tumors

Cancer researchers at Georgetown University Medical Center have discovered a key marker in breast cancer tumors that may help determine which women with early stage breast cancer have a better chance of survival. The research appears in the June 1 issue of the Journal of Clinical Oncology.

31 May 2004

There are still benefits from hormone therapy after menopause

Despite the highly publicized closing of the Women’s Health Initiative study, the scientific community should not rule out that women may benefit from hormone therapy after menopause, say researchers at UC Davis, Duke and Harvard Universities.

31 May 2004